Come join us at Oxford Global’s Biologics conference (Sep. 6-7, 2021)! CEO Jens Frauenfeld will be speaking about the latest development on the Salipro one-step reconstitution of membrane protein drug targets, and Business Development Director Maria Lisa Knudsen will discuss antibody discovery using the Salipro platform. Looking forward to some good discussions!
